May
06
J&J Launches Massive Corporate-Image Rebranding Campaign
Posted in: Uncategorized
Recalls, lawsuits, investigations — Johnson & Johnson has had them in droves.
Quality problems and recalls of Tylenol and other brands since 2010 led the Food and Drug Administration to mandate manufacturing shutdowns and improvements that still aren’t done. J&J also faces more than 10,000 lawsuits over alleged failures of its Depuy metal-on-metal hip transplants and last year paid $181 million to settle state lawsuits over off-label marketing of its Risperdal antipsychotic drug.
But markets have shrugged. J&J’s stock is up 32% in the past year. And as some Motrin and Tylenol products returned to shelves last year, sales soared.
Post a Comment